AEON Biopharma
AEON
AEON
24 hedge funds and large institutions have $8.73M invested in AEON Biopharma in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
9
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
+$94.6K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$50.7K |
| 3 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$47.7K |
| 4 |
BlackRock
New York
|
+$17.7K |
| 5 |
KL
KIM LLC
Wichita,
Kansas
|
+$16.3K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$331K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$248K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$167K |
| 4 |
Goldman Sachs
New York
|
-$166K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$60.3K |
